Literature DB >> 25714311

Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.

Andrew B Rosenkrantz1, Sooah Kim, Naomi Campbell, Byron Gaing, Fang-Ming Deng, Samir S Taneja.   

Abstract

OBJECTIVE. The purpose of this study was to retrospectively evaluate the impact of multiparametric prostate MRI, including diffusion-weighted imaging (DWI) performed using different b values as well as dynamic contrast-enhanced MRI (DCE-MRI) on the accuracy, sensitivity, and specificity for transition zone (TZ) tumor detection and localization. MATERIALS AND METHODS. We included 106 prostate cancer patients (mean age [± SD], 62 ± 7 years) who underwent 3-T MRI with a pelvic phased-array coil before radical prostatectomy. Three radiologists independently reviewed cases to record the likelihood of tumor in each of six TZ regions. Scores were initially assigned using T2-weighted imaging alone, reassigned after integration of DWI at b = 1000 s/mm(2) and corresponding apparent diffusion coefficient (ADC) maps, reassigned again after integration of DWI at b = 2000 s/mm(2), and reassigned a final time after integration of DCE-MRI. Generalized estimating equations based on binary logistic regression were used to compare sessions for TZ tumor detection, using prostatectomy findings as reference standard. RESULTS. Of the TZ sextants, 9.7% (62/636) contained tumor. All readers had higher sensitivity for T2-weighted imaging integrated with DWI at b = 1000 s/mm(2) and ADC compared with T2-weighted imaging alone (reader 1, 54.8% vs 33.9%; reader 2, 53.2% vs 22.6%; and reader 3, 50.0% vs 19.4% [p ≤ 0.002]); two readers had further increased sensitivity also incorporating b = 2000 s/mm(2) (reader 1, 74.2% and reader 2, 62.9%; p ≤ 0.011), and one reader had further increased sensitivity also incorporating both b = 2000 s/mm(2) and DCE-MRI (reader 3, 61.3%, p = 0.013). DCE-MRI otherwise did not improve sensitivity (p ≥ 0.054). Other measures were similar across the four sessions (reader 1, specificity 97.4-98.3% and accuracy 91.2-95.9%; reader 2, specificity 95.8-98.4% and accuracy 91.0-92.6%; reader 3, specificity 90.9-96.7% and accuracy 88.1-89.2%). CONCLUSION. DWI assists TZ tumor detection through higher sensitivity, particularly when using a very high b value; DCE-MRI lacks further additional benefit.

Entities:  

Keywords:  MRI; diffusion-weighted imaging; dynamic contrast-enhanced imaging; prostate cancer; transition zone

Mesh:

Year:  2015        PMID: 25714311     DOI: 10.2214/AJR.14.12955

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  23 in total

1.  Dynamic contrast-enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer.

Authors:  Justin M Ream; Ankur M Doshi; Diane Dunst; Nainesh Parikh; Max X Kong; James S Babb; Samir S Taneja; Andrew B Rosenkrantz
Journal:  J Magn Reson Imaging       Date:  2016-09-20       Impact factor: 4.813

2.  Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance.

Authors:  J P Radtke; S Boxler; T H Kuru; M B Wolf; C D Alt; I V Popeneciu; S Steinemann; C Huettenbrink; C Bergstraesser-Gasch; T Klein; C Kesch; M Roethke; N Becker; W Roth; H-P Schlemmer; M Hohenfellner; B A Hadaschik
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-06-16       Impact factor: 5.554

3.  Clinical impact of ultra-high b-value (3000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3T: comparison with b-value of 2000 s/mm2.

Authors:  Tsutomu Tamada; Ayumu Kido; Yu Ueda; Mitsuru Takeuchi; Takeshi Fukunaga; Teruki Sone; Akira Yamamoto
Journal:  Br J Radiol       Date:  2021-09-24       Impact factor: 3.039

4.  Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?

Authors:  Ely R Felker; Steven S Raman; Daniel J Margolis; David S K Lu; Nicholas Shaheen; Shyam Natarajan; Devi Sharma; Jiaoti Huang; Fred Dorey; Leonard S Marks
Journal:  AJR Am J Roentgenol       Date:  2017-08-31       Impact factor: 3.959

Review 5.  Targeted Anterior Gland Focal Therapy-a Novel Treatment Option for a Better Defined Disease.

Authors:  Kae Jack Tay; Arnauld Villers; Thomas J Polascik
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

6.  Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.

Authors:  Katsuhiro Ito; Akihiro Furuta; Akira Kido; Yuki Teramoto; Shusuke Akamatsu; Naoki Terada; Toshinari Yamasaki; Takahiro Inoue; Osamu Ogawa; Takashi Kobayashi
Journal:  Int J Clin Oncol       Date:  2019-12-02       Impact factor: 3.402

7.  Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results.

Authors:  Thomas Auer; Michael Edlinger; Jasmin Bektic; Udo Nagele; Thomas Herrmann; Georg Schäfer; Friedrich Aigner; Daniel Junker
Journal:  World J Urol       Date:  2016-08-10       Impact factor: 4.226

8.  Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes.

Authors:  Arnauld Villers; Philippe Puech; Vincent Flamand; Georges-Pascal Haber; Mihir M Desai; Sebastien Crouzet; Xavier Leroy; Sameer Chopra; Laurent Lemaitre; Adil Ouzzane; Inderbir S Gill
Journal:  Eur Urol       Date:  2016-09-06       Impact factor: 20.096

9.  Diagnostic Performance of PI-RADS v2, Proposed Adjusted PI-RADS v2 and Biparametric Magnetic Resonance Imaging for Prostate Cancer Detection: A Preliminary Study.

Authors:  Guan-Hui Cai; Qi-Hua Yang; Wen-Bo Chen; Qing-Yu Liu; Yu-Rong Zeng; Yu-Jing Zeng
Journal:  Curr Oncol       Date:  2021-05-12       Impact factor: 3.677

10.  Diagnostic accuracy of high b-value diffusion weighted imaging for patients with prostate cancer: a diagnostic comprehensive analysis.

Authors:  Chao Li; Na Li; Zhanzhan Li; Liangfang Shen
Journal:  Aging (Albany NY)       Date:  2021-06-22       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.